Connection

Adviye Ergul to Neuroprotective Agents

Back to Details
This is a "connection" page, showing publications Adviye Ergul has written about Neuroprotective Agents.
Adviye Ergul
Connection Strength
2.282
Neuroprotective Agents
  1. Delayed Administration of Angiotensin Receptor (AT2R) Agonist C21 Improves Survival and Preserves Sensorimotor Outcomes in Female Diabetic Rats Post-Stroke through Modulation of Microglial Activation. Int J Mol Sci. 2021 Jan 29; 22(3).
    View in: PubMed
    Score: 0.585
  2. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. Pharmacol Res. 2019 04; 142:237-250.
    View in: PubMed
    Score: 0.512
  3. Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes. Am J Physiol Heart Circ Physiol. 2013 Mar 15; 304(6):H806-15.
    View in: PubMed
    Score: 0.336
  4. Angiotensin II type 2 receptor stimulation with compound 21 improves neurological function after stroke in female rats: a pilot study. Am J Physiol Heart Circ Physiol. 2019 05 01; 316(5):H1192-H1201.
    View in: PubMed
    Score: 0.128
  5. Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial. Stroke. 2017 10; 48(10):2885-2887.
    View in: PubMed
    Score: 0.116
  6. Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension. PLoS One. 2017; 12(6):e0178867.
    View in: PubMed
    Score: 0.114
  7. Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injury. Eur J Pharmacol. 2017 Mar 15; 799:128-134.
    View in: PubMed
    Score: 0.111
  8. Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B. J Pharmacol Exp Ther. 2014 Jun; 349(3):444-57.
    View in: PubMed
    Score: 0.091
  9. Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential. Stroke. 2009 Sep; 40(9):3028-33.
    View in: PubMed
    Score: 0.066
  10. Targets for vascular protection after acute ischemic stroke. Stroke. 2004 Sep; 35(9):2220-5.
    View in: PubMed
    Score: 0.047
  11. Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke. Am J Physiol Regul Integr Comp Physiol. 2004 Feb; 286(2):R283-8.
    View in: PubMed
    Score: 0.044
  12. Neurovascular protection in voltage-gated proton channel Hv1 knock-out rats after ischemic stroke: interaction with Na+ /H+ exchanger-1 antagonism. Physiol Rep. 2019 08; 7(13):e14142.
    View in: PubMed
    Score: 0.033
  13. Silencing VEGF-B Diminishes the Neuroprotective Effect of Candesartan Treatment After Experimental Focal Cerebral Ischemia. Neurochem Res. 2018 Oct; 43(10):1869-1878.
    View in: PubMed
    Score: 0.031
  14. Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals - A randomized double- blind pre-clinical study. Behav Brain Res. 2018 07 02; 346:29-40.
    View in: PubMed
    Score: 0.029
  15. Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke. Mol Neurobiol. 2017 01; 54(1):661-670.
    View in: PubMed
    Score: 0.026
  16. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci. 2006 Jul 17; 7:56.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.